Status:
COMPLETED
Examining the Influence of Guided Meditation on Diabetes-related Distress and Glycemic Control
Lead Sponsor:
Shifa International Hospital
Conditions:
Type 1 Diabetes Mellitus
Eligibility:
All Genders
12-18 years
Phase:
NA
Brief Summary
The study aims to investigate the effects of Guided Meditation on diabetes-related distress and glycemic control in hospitalized Type 1 adolescent diabetic patients. The study will employ a randomized...
Detailed Description
The researchers hypothesize that the intervention group will experience a reduction in diabetes-related distress and an improvement in glycemic control compared to the control group. The study's findi...
Eligibility Criteria
Inclusion
- Adolescent patients aged between 12 to 18 years.
- Confirmed diagnosis of Type 1 diabetes mellitus.
- Hospitalized in the participating medical facility.
- Capable of providing informed consent (for participants aged 18) or providing assent with parental/legal guardian consent (for participants aged 12 to 17).
Exclusion
- Presence of severe psychiatric disorders or cognitive impairments that may hinder participation in the guided meditation sessions.
- Physical limitations or medical conditions that prevent the safe participation in the intervention or assessment procedures.
- Previously engaged in regular meditation or mindfulness practices, which may confound the results.
- Inability to communicate effectively in the language used for assessments and interventions.
Key Trial Info
Start Date :
August 1 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 3 2023
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT06151821
Start Date
August 1 2023
End Date
October 3 2023
Last Update
November 30 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Shifa Hospital
Lahore, Pakistan